Sign in
CompletedNo phase

Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department

Key facts

Who runs it
University of Vermont
Where
Burlington, United StatesSee the site
Trial code
Status
Completed
People taking part
12 people enrolled
Started
2 Sept 2025
Ended
16 Oct 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Contingency Management
  • Usual care as prescribed by the ED physicians
Record updated
20 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who cannot take part

  • Pending incarceration in the next 30 days
  • Plan to leave the area (Burlington/Chittenden County) in the next 30 days
  • Physical, health, or structural challenge that prevents attendance at outpatient clinic

Other criteria

  • Major inclusion criteria include
  • STAR referral to outpatient clinic (Addiction Treatment Center and Chittenden Clinic) with prescription for buprenorphine or methadone
  • Age ≥18 years
  • Provide informed consent

Where in United States

  • University of Vermont Medical CenterBurlington, United States

About the trial

What the trial wants to find out

Project Summary The goal of this pilot clinical trial is to assess contingency management (CM) for increasing attendance at outpatient clinics after Medication for Opioid Use Disorder (MOUD) prescription and clinic referral occurred in the hospital Emergency Department (ED).

Read full original descriptionShow less

* The researchers will compare usual care (UC)+CM to UC alone to see if 1) CM works to promote MOUD clinic attendance after discharge from the ED and 2) demonstrate feasibility of providing CM in the ED and outpatient MOUD clinic settings. * Researchers will randomize 30 adults who started MOUD in the ED into two conditions. These conditions consist of (A) UC alone: A referral to an outpatient buprenorphine or methadone provider with reminders from STAR program staff or (B) UC+CM: UC plus financial incentives dependent on MOUD clinic attendance to receive an MOUD prescription.

The primary outcome of interest is the number of participants who receive their first MOUD prescription from the outpatient clinic after discharge from the ED in UC+CM compared to the UC-only condition. A secondary outcome will be the proportion of participants who kept attending outpatient MOUD treatment by the end of the 30-day study period between UC+CM and UC conditions. An exploratory outcome will be biochemically-verified illicit opioid abstinence measured at day 30.

The 2 groups in the trial

  • Contingency ManagementTreatment being tested

    Participants assigned to this arm will receive incentives when they complete their first outpatient MOUD clinic visit and when they complete subsequent visits to pick up their MOUD prescription for the 30-day study period.

    Treatment: Contingency Management and Usual care as prescribed by the ED physicians

  • Usual CareExisting treatment, for comparison

    All participants will receive standard outpatient care at their clinic.

    Treatment: Usual care as prescribed by the ED physicians

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Contingency Management to Improve Medication for Opioid Use Disorder Continuation After Discharge From the Emergency Department
Record updated
20 October 2026